Retour à l'accueil - Logo MICAH

Microenvironnement et cancers hématologiques

Home > STAFF


Gandhi Laurent Damaj

MD, PhD
University of Caen Normandy
University Hospital of Caen
 damaj-gl@chu-caen.fr
 + 33 2 31 27 21 40 (administration office)


Projects

  • Characterization of new drugs effective for peripheral T-cell lymphoma and systemic mastocytosis 
  • Role of BRD4 and its inhibitors in T-cell proliferation

Skills

  • Non-Hodgkin lymphoma including T-cell lymphoma
  • Systemic mastocytosis

Five selected recent publications

  • MonnierJ, Georgin-Lavialle S, Canioni D, Lhermitte L, Soussan M, Arock M, Bruneau J, Dubreuil P, Bodemer C, Chandesris MO, Lortholary O, Hermine O, Damaj G. Mast cell sarcoma: new cases and literature review. Oncotarget 2016, in press. doi: 10.18632/oncotarget.11812.
    PMID: 2760277

  • Reboursiere E, Le Bras F, Herbaux C, Gyan E, Clavert A, Morschhauser F, Malak S, Sibon D, Broussais F, Braun T, Fornecker LM, Garidi R, Tricot S, Houot R, Joly B, Abarah W, Choufi B, Pham AD, Gac AC, Fruchart C, Marin E, Safar V, Parcelier A, Maisonneuve H, Bachy E, Cartron G, Jaccard A, Tournilhac O, Rossi C, Schirmer L, Martignoles JA, Gaulard P, Tilly H, Damaj G, Lymphoma Study Association Lysa Centers. Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Oncotarget 2016, in press. doi: 10.18632/oncotarget.10764.
    PMID: 27458168

  • Damaj G, Ivanoff S, Coso D, Ysaebert L, Choquet S, Houillier C, Parcelier A, Abarah W, Marjanovic Z, Gressin R, Garidi R, Diouf M, Gac AC, Dupuis J, Troussard X, Morschhauseur F, Ghesquières H, Soussain C; LYSA and LOC network, France. Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network. Haematologica 2015;100(9):1199-206. 
    PMID: 26185174

  • Paccou J, Merlusca L, Henry-Desailly I, Parcelier A, Gruson B, Royer B, Charbonnier A, Ursu D, Desailloud R, Garidi R, Kamel S, Sevestre H, Marolleau JP, Fardellone P, Damaj G. Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. Ann Oncol 2014;25(2):481-6.
    PMID: 24401926

  • Damaj G, Gressin R, Bouabdallah K, Cartron G, Choufi B, Gyan E, Banos A, Jaccard A, Park S, Tournilhac O, Schiano-de Collela JM, Voillat L, Joly B, Le Gouill S, Saad A, Cony-Makhoul P, Vilque JP, Sanhes L, Schmidt-Tanguy A, Bubenheim M, Houot R, Diouf M, Marolleau JP, Béné MC, Martin A, Lamy T. Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial. J Clin Oncol 2013;31(1):104-10. doi: 10.1200/JCO.2012.43.7285.
    PMID: 23109692.
View full list of publications...

Download page

Last update : January 12, 2017



Université de Caen Normandie
équipe MICAH
CHU niveau 3 | 5 avenue de la Côte de Nacre | 14032 Caen Cedex 5 | France